跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-GLYBURIDE TABLET 5 mg - HSA Drug Approval Details
Approvals
/
HSA
/
APO-GLYBURIDE TABLET 5 mg
Approved
THERAPEUTIC
APO-GLYBURIDE TABLET 5 mg
APOTEX INC
🇸🇬 Health Sciences Authority
Approval Date
Jun 26, 1990
Approval ID
6afb09fe7cdb9737
Company
APOTEX INC
Type
Therapeutic
Approval Details
Approval Id
6afb09fe7cdb9737
Drug Name
APO-GLYBURIDE TABLET 5 mg
Product Name
APO-GLYBURIDE TABLET 5 mg
Approval Number
SIN04842P
Approval Date
1990-06-26
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
A10BB01
Atc Item Name
glibenclamide
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
GLIBENCLAMIDE
5 mg
GLIBENCLAMIDE
5 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 26, 1990
Approval ID
6afb09fe7cdb9737
Type
Therapeutic
Back to HSA Approvals